HEPTARES THERAPEUTICS LIMITED

AL7 3AX (East of England)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£1,504,140

Mar 15 - Mar 18

Pre-clinical development of a novel oral therapy for hyperinsulinemic hypoglycaemia

Innovate UK award to HEPTARES THERAPEUTICS LIMITED and Carolyn Smith

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}